Day: September 26, 2023

Datacubed Health and AppInChina Forge Strategic Partnership to Launch eClinical Platform in China

New York, New York, Sept. 26, 2023 (GLOBE NEWSWIRE) — Datacubed Health, a leading global provider of innovative solutions for patient engagement and data collection in clinical trials, is excited to announce the official launch of its eClinical platform app in China. This milestone achievement represents a significant step forward for Datacubed Health’s commitment to expanding its presence in the Chinese market.

As part of this strategic move, Datacubed Health has joined forces with AppInChina, a renowned leader in Android App Store publication, ensuring seamless deployment of the eClinical platform app in official Android stores across China and the Apple App Store. This partnership guarantees accessibility to a wide range of devices and ecosystems.

Kyle Hogan, President of Datacubed Health, emphasized the importance of this collaboration: “Our partnership with AppInChina has been instrumental in ensuring the smooth launch of our eClinical platform app in China. This strategic alliance allows us to reach a broader audience while maintaining compliance with local regulations, which is essential for our growth in this market.”

In preparation for this momentous launch, Datacubed Health has established a legal entity within China and acquired all necessary commercial and legal licenses and certificates. These crucial steps are a testament to Datacubed Health’s commitment to providing secure and regulated services within the Chinese market.

Brett Kleger, CEO of Datacubed Health, stated, “Our investment in establishing a legal presence and obtaining the requisite licenses underscores our dedication to operating ethically and responsibly in China. We are focused on delivering cutting-edge solutions while adhering to local regulations and standards.”

Moreover, Datacubed Health has undertaken comprehensive efforts to ensure full software compliance with Chinese regulations. The eClinical platform app for China has been meticulously customized to align with local requirements and has undergone rigorous testing by local quality assurance teams. This meticulous approach ensures the seamless functioning of the platform while adhering to Chinese network security requirements and restrictions.

Datacubed Health has also bolstered its presence in China by establishing a fully compliant and fault-tolerant Software as a Service (SaaS) infrastructure. The Datacubed China solution is now hosted in AWS Beijing, ensuring data security and reliability for users in the region.

With these key developments in operational, legal, and software compliance, Datacubed Health is well-prepared to provide unmatched support to clinical research efforts in China. The launch of the eClinical platform app represents a significant stride in bridging the gap between global research initiatives and the Chinese healthcare landscape.

In the words of CEO Brett Kleger: “We are thrilled to introduce Datacubed Health’s eClinical platform app to the Chinese market. Our partnership with AppInChina, legal entity establishment, and rigorous compliance efforts demonstrate our dedication to providing world-class services to our Chinese users. We look forward to empowering clinical research initiatives in China with our cutting-edge solutions.”

To learn more, we invite you to join us at Booth #24 at the 11th Annual Outsourcing in Clinical Trials Southern California 2023 from September 26-27 in San Diego, California, or visit our website at www.datacubed.com.

About Datacubed Health:

Datacubed Health is a pioneering eClinical technology company built from the ground up by industry veterans who wanted to create a better clinical trial experience for all stakeholders. Our solutions are all infused with neuroeconomic principles designed to be inclusive, drive compliance, and greatly improve retention. We strive to deliver the best experience for you and your patients through ease of use and flexible technology configurable to your needs. Our offerings include a Decentralized Trials Platform, eCOA/ePRO, Patient Engagement, eConsent, Medication Adherence, Televisits, and Geofencing. Learn more at www.datacubed.com.

Media Contact:
Heather Shea
Catalytic Agency for Datacubed Health
heather.shea@catalyticagency.com

Jillian Tygh
Datacubed Health
2672543997
jillian.tygh@datacubed.com

GlobeNewswire Distribution ID 8926943

Futoshi Saito Joins as President & General Manager, Japan

BOSTON, Sept. 26, 2023 (GLOBE NEWSWIRE) — Anaqua, the leading global innovation and intellectual property (IP) management technology provider, today announced changes to its executive leadership team in Japan as the company continues its strong growth trajectory in the country. Futoshi Saito will join Anaqua Japan, effective October 10, 2023, as President & General Manager, responsible for driving Anaqua’s ongoing business development and delivering enhanced client solutions in Japan.

Saito-san has previously held leadership positions at LexisNexis as Managing Director, Japan and South Korea, and Thomson Reuters (now part of Clarivate) as head of the IP & Science business in Japan. Saito-san holds a bachelor’s degree in international studies from Dokkyo University and studied at the Graduate School of History at the State University of New York at Albany.

Anaqua also announced the opening of its new Japan headquarters in the TOKYO TORCH Tokiwabashi Tower, providing an expanded work space to support the company’s accelerated growth, which has seen further strengthening of the team and a 50% increase in new sales YTD . The move continues Anaqua Japan’s mission to invest in people, infrastructure and solutions in order to provide clients with the most comprehensive and effective IP management software and solutions in Japan. Other recent Anaqua investments in Japan include opening a second client datacenter on Microsoft Azure, hiring additional team members for the growing annuities and renewals business, and developing Japan-specific enhancements to the AQX IP management platform, both for the pharmaceutical market and trademark professionals.

“I am excited to join Anaqua, a company I have admired for many years over the course of my career in IP and legal technology,” said Saito. “I am honored to lead Anaqua Japan through its next stage of growth and to help our clients better protect and maximize value from their IP portfolios.”

Anaqua CEO Bob Romeo said: “We are delighted to have appointed Saito-san to lead Anaqua’s business in Japan. His extensive IP and technology experience will enable him to engage quickly with our business and the wider market, forming important relationships with our existing and future clients, and providing strong leadership for our team and our further business development. I am very proud of our operations in Japan and I am excited for what is yet to come.”

About Anaqua

Anaqua, Inc. is a premier provider of integrated intellectual property (IP) management technology solutions and services for corporations and law firms. Its IP management software solutions, AQX and PATTSY WAVE, both offer best practice workflows with big data analytics and tech-enabled services to create an intelligent environment designed to inform IP strategy, enable IP decision-making, and streamline IP operations, tailored to each segment’s need. Today, nearly half of the top 100 U.S. patent filers and global brands, as well as a growing number of law firms worldwide use Anaqua’s solutions. Over one million IP executives, attorneys, paralegals, administrators, and innovators use the platform for their IP management needs. The company’s global operations are headquartered in Boston, with offices across the U.S., Europe, and Asia Pacific. For additional information, please visit anaqua.com, or on LinkedIn.

GlobeNewswire Distribution ID 8927986